Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies

Jing Wang1,2, Zhijie Luo3, Lizhu Lin3

  • 1State Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau 999078, China.

Cancers
|October 14, 2022
PubMed

Insights

Anoikis, a form of apoptosis, prevents lung cancer metastasis by anchoring cells to the extracellular matrix. Targeting anoikis regulators offers a promising therapeutic strategy for treating lung cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Lung cancer metastasis is a primary cause of treatment failure.
  • Anoikis, a programmed cell death, is crucial in preventing cancer cell dissemination.
  • Understanding anoikis regulation is vital for developing effective lung cancer therapies.

Purpose of the Study:

  • To review the molecular mechanisms regulating anoikis in lung cancer metastasis.
  • To identify key regulators of anoikis involved in lung cancer progression.
  • To discuss the therapeutic potential of targeting anoikis for lung cancer treatment.

Main Methods:

  • Literature review of studies on anoikis and lung cancer metastasis.
  • Analysis of molecular mechanisms underlying anoikis regulation.
  • Summary of natural and synthetic compounds with pro-anoikis activity.

Main Results:

  • Anoikis effectively inhibits tumor cell escape from the extracellular matrix, thus combating metastasis.
  • Several natural products (e.g., artonin E, sulforaphane) and synthetic compounds show pro-anoikis potential.
  • Specific molecular regulators and pathways governing anoikis in lung cancer have been identified.

Conclusions:

  • Targeting anoikis represents a viable therapeutic strategy to combat lung cancer metastasis.
  • Further research into anoikis mechanisms can lead to novel anti-metastatic drugs.
  • Modulating anoikis holds significant promise for improving lung cancer patient outcomes.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K